Immunovant secures $450M private placement for IMVT-1402 development, while Biomea shifts focus to diabetes, and multiple companies announce deals and organizational changes.

ON CRISPR enzyme, will combine with RNA guides for pharma customers. Deal follows HuidaGene agreement, offers 99% cost ...

South Africa’s coalition government, described by President Cyril Ramaphosa as the country’s ‘second miracle’, seems ...

US singer Sean Garrett has reacted to rumours of Basketball Wives star Brooke Bailey dating Nigerian singer, Timaya. His ...

After decades of trying to do so, Ethiopia is now on course to launch its first-ever stock exchange later this year ...

Heimdal, a top European cybersecurity company, is teaming up with Watsoft, a French IT distributor focused on Managed Service Providers ...

The government has invited bids for massive sea and river defence works including for one Mahaica project where the ...

The Tampere Psychiatric Clinic sets a standard in mental health care facilities by seamlessly blending nature, cultural ...

CBIH is proud to announce that Brian Cuban, Esq., a distinguished attorney, best-selling author, mental health advocate, and esteemed member of our Advisory Board, has officially joined the ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Bamia School finished save for pathway Rawle Ferguson, one of the principals of St8tment Investment Inc, recently accused ...